BRCA1 and BRCA2 are tumour suppressor genes, and this test identifies gene mutations. Alterations increase cancer risk, particularly in breast, ovarian, colon, pancreas, and stomach cancers in females and breast, pancreatic, testicular, and prostate cancers in males. Healthcare professionals employ this test when suspecting such malignancies, aiding in early detection and tailored treatment strategies.